Clinical Trial Update: Study to Evaluate the Efficacy and Safety of CKD-352 [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating CKD-352 for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• CKD-352

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED